Accepted and controversial neuromotor therapies for infants at high risk for cerebral palsy.
Neuromotor therapies are prescribed frequently for infants at high risk for cerebral palsy or other central nervous system (CNS) disorders. Based on the concept of early CNS plasticity, neuromotor therapies are important components of early intervention programs. The purposes of this review article are (1) to describe five neuromotor therapies commonly used in the United States, Europe, and the Far East; (2) to briefly present research results of efficacy studies using these various therapies; (3) to discuss similarities and differences among the various approaches; (4) to highlight controversies surrounding some of these approaches; and (5) to present suggestions for future research on examining efficacy of early neuromotor therapy.